Project

CARE1 in a few words

Focused on pragmatic clinical trials, CARE1 is an European project aiming to improve the first-line treatment for patients with metastatic kidney cancer by implementing a routine biomarker, leveraging a unique academic network in Europe.

1,200

Patients

8+

Countries

100

Participating hospitals in Europe

7+

Associated research programs

CARE1 in a few words

Outcome

CARE1 was designed to determine the optimal combination for patients using a routine implementable biomarker. CARE1 will establish a large-scale platform to define the best standard of treatment based on a routine biomarker to enhance treatment efficacy. In the long term, a data collection effort, including the creation of a pathological and blood biobank, will be conducted on a European scale.

Innovation

This project also aims to innovate healthcare, patient care and research by exploring the use of AI in diagnostics and clinical research, and the use of digital tools for patient care.

Our latest articles

To view more, visit our Blog page

2024-05-01 •

Kudos for the new #CARE1 ...

Such a crystal clear, thoughtful approach to doublets from @AlbigesL as front line for metastatic #kidneycancer! Doublets are now established standard in trials AND the need for biomarkers for future patient/tx selection. Kudos for the new #CARE1 trial underway in EU! #ASCO23...

2024-05-01 •

CARE1_Kick-off Meeting...

"« We are pleased to announce the launch of #CARE1 Project, which officially started on May 1st, 2023. The project was submitted under the Call HORIZON-MISS-2022-CANCER-01-03, focused on pragmatic clinical trials to optimize treatments for patients with refractory cancers. ...

2024-05-01 •

📢 Launch of the pragmatic...

📢 Launch of the pragmatic CARE-1 clinical trial coordinated by Pr @AlbigesL @GustaveRoussy. A key step in the future of kidney cancer care #CARE1 #ClinicalResearch #HealthCareInnovation @HorizonEU...